Pharmaceutical Solutions Division in video

Terumo Corporation (TSE: 4543) will be renaming the “General Hospital Company” to its new name “Medical Care Solutions Company” effective from April 1, 2022. Concurrently, the Medical Care Solutions Company will launch its new brand “Terumo Medical Care Solutions (TMCS)” and restructure its organization, in order to achieve continued growth and work towards Terumo’s 5-Year Growth Strategy (GS26).

Access world-class CDMO capabilities.
We provide sterile injectable CDMO from clinical to commercial scale. Drawing on 100 years of expertise, our integrated services include combination product design, formulation development, aseptic fill & finish, device assembly and packaging.

Pharmapack 2023 showcased a number of sessions on the key topics in the industry, from conference sessions to workshops, presented by experts in the field. 

In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We chatted to Marco Chiadò Piat (President) and Anil Busimi (VP Strategy and Marketing) of Terumo Pharmaceutical Solutions about how events such as CPHI can help all companies across the pharmaceutical supply chain. 

PLAJEX™ 2.25 ml withTapered Needle for Biotech Formulations
A simple formula for biotech success